METHODS
Accepted on 10 Nov 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Exploring the role of immune cells and cell therapy in liver cancer
Exploring the role of immune cells and cell therapy in liver cancer
12k
Total downloads
43k
Total views and downloads
Articles
REVIEW
Published on 16 Apr 2025
Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1569150
- 1,711 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Apr 2025
Stimulation of regulatory dendritic cells suppresses cytotoxic T cell function and alleviates DEN-induced liver injury, fibrosis and hepatocellular carcinoma
doi 10.3389/fimmu.2025.1565486
- 2,373 views
ORIGINAL RESEARCH
Published on 20 Feb 2025
Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing
doi 10.3389/fimmu.2025.1529569
- 3,001 views
REVIEW
Published on 12 Dec 2024
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma
doi 10.3389/fimmu.2024.1501659
- 3,958 views
- 9 citations
REVIEW
Published on 08 Nov 2024
Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments
doi 10.3389/fimmu.2024.1459942
- 2,586 views
- 1 citation
MINI REVIEW
Published on 06 Nov 2024
CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
doi 10.3389/fimmu.2024.1489649
- 8,183 views
- 20 citations
ORIGINAL RESEARCH
Published on 03 Sep 2024
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study
doi 10.3389/fimmu.2024.1463574
- 2,311 views
- 3 citations
REVIEW
Published on 03 Sep 2024
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
doi 10.3389/fimmu.2024.1460282
- 6,675 views
- 18 citations
SYSTEMATIC REVIEW
Published on 30 Aug 2024
Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis
doi 10.3389/fimmu.2024.1466113
- 2,970 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore